Document is current
Any future updates will be listed below
-
Authors
Boye, Kristina S.
Cutts, Katelyn N.
Coyne, Karin S.
Matza, Louis S.
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 1 September 2025
Accepted: 20 November 2025
First Online: 12 February 2026
Declarations
:
: Kristina Boye is employed by and owns shares in Eli Lilly and Company. Louis Matza, Katelyn Cutts, and Karin Coyne are employed by Thermo Fisher Scientific, which received funding from Lilly for the time spent conducting this research.
: All study methods and materials, as well as all eight clinical sites participating in the study, were approved by an independent review board (Salus Institutional Review Board study number 23069). The study was performed according to the Helsinki Declaration of 1964 and its later amendments. Participants provided informed consent before completing any study measures and were remunerated for their time. The consent form informed participants that their data may be published, but they would not be personally identified in any publications.
